| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥6.43 |
| 52 Week High | CN¥10.21 |
| 52 Week Low | CN¥5.20 |
| Beta | 0.12 |
| 11 Month Change | 2.06% |
| 3 Month Change | -11.19% |
| 1 Year Change | -24.09% |
| 33 Year Change | -12.64% |
| 5 Year Change | 6.11% |
| Change since IPO | -51.82% |
Recent News & Updates
Shareholder Returns
| 002566 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 0.3% | 0.05% | -1.6% |
| 1Y | -24.1% | -11.8% | -19.6% |
Return vs Industry: 002566 underperformed the CN Pharmaceuticals industry which returned -11.8% over the past year.
Return vs Market: 002566 underperformed the CN Market which returned -19.6% over the past year.
Price Volatility
| 002566 volatility | |
|---|---|
| 002566 Average Weekly Movement | 4.3% |
| Pharmaceuticals Industry Average Movement | 5.2% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in CN Market | 9.0% |
| 10% least volatile stocks in CN Market | 3.8% |
Stable Share Price: 002566 has not had significant price volatility in the past 3 months.
Volatility Over Time: 002566's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 1,678 | Xiaomin Xue | www.yisheng-pharm.com |
Jilin Jian Yisheng Pharmaceutical Co., Ltd. manufactures and sells medicine, Chinese herbal medicine, cosmetics, and ginseng products in China. The company offers injections, tablets, granules, hard capsules, mixtures, eye drops, liniments, liquors, syrups, emulsions, and other raw materials.
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Fundamentals Summary
| 002566 fundamental statistics | |
|---|---|
| Market cap | CN¥2.13b |
| Earnings (TTM) | CN¥87.05m |
| Revenue (TTM) | CN¥803.08m |
24.4x
P/E Ratio2.6x
P/S RatioIs 002566 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 002566 income statement (TTM) | |
|---|---|
| Revenue | CN¥803.08m |
| Cost of Revenue | CN¥198.98m |
| Gross Profit | CN¥604.10m |
| Other Expenses | CN¥517.05m |
| Earnings | CN¥87.05m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 24, 2024
| Earnings per share (EPS) | 0.26 |
| Gross Margin | 75.22% |
| Net Profit Margin | 10.84% |
| Debt/Equity Ratio | 20.0% |
How did 002566 perform over the long term?
See historical performance and comparison